Teyi Pharmaceutical Group Co Ltd (002728) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.029x

Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.94 Million ≈ $7.75 Million USD) by net assets (CN¥1.84 Billion ≈ $269.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002728 net asset quality score to measure how much of total assets are equity-financed.

Teyi Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Teyi Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Teyi Pharmaceutical Group Co Ltd (002728) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Teyi Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teyi Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Yasha Decoration Co Ltd SHE:002375	-0.009x
Max Estates Limited NSE:MAXESTATES	-0.096x
Mah Sing Group Bhd KLSE:8583	-0.035x
Park Aerospace Corp NYSE:PKE	0.048x
Pilkington Deutschland AG HM:FDD	N/A
Hainan Shennong Technology Co Ltd SHE:300189	0.008x
ChemPartner PharmaTech Co Ltd SHE:300149	0.022x
Tanac Automation Co Ltd SHE:300461	-0.051x

Annual Cash Flow Conversion Efficiency for Teyi Pharmaceutical Group Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Teyi Pharmaceutical Group Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.84 Billion ≈ $269.06 Million	CN¥244.88 Million ≈ $35.83 Million	0.133x	+1142.38%
2024-12-31	CN¥1.76 Billion ≈ $258.27 Million	CN¥-22.55 Million ≈ $-3.30 Million	-0.013x	-112.94%
2023-12-31	CN¥2.01 Billion ≈ $294.23 Million	CN¥198.56 Million ≈ $29.06 Million	0.099x	-62.72%
2022-12-31	CN¥1.40 Billion ≈ $205.32 Million	CN¥371.66 Million ≈ $54.39 Million	0.265x	+30.13%
2021-12-31	CN¥1.26 Billion ≈ $184.62 Million	CN¥256.81 Million ≈ $37.58 Million	0.204x	+30.14%
2020-12-31	CN¥1.08 Billion ≈ $158.10 Million	CN¥168.99 Million ≈ $24.73 Million	0.156x	-18.63%
2019-12-31	CN¥1.15 Billion ≈ $168.73 Million	CN¥221.64 Million ≈ $32.43 Million	0.192x	+13.64%
2018-12-31	CN¥1.11 Billion ≈ $162.60 Million	CN¥187.97 Million ≈ $27.51 Million	0.169x	+71.34%
2017-12-31	CN¥1.04 Billion ≈ $152.60 Million	CN¥102.96 Million ≈ $15.07 Million	0.099x	-13.59%
2016-12-31	CN¥886.57 Million ≈ $129.73 Million	CN¥101.30 Million ≈ $14.82 Million	0.114x	+33.44%
2015-12-31	CN¥804.30 Million ≈ $117.69 Million	CN¥68.87 Million ≈ $10.08 Million	0.086x	+9.84%
2014-12-31	CN¥735.64 Million ≈ $107.65 Million	CN¥57.35 Million ≈ $8.39 Million	0.078x	-63.23%
2013-12-31	CN¥350.14 Million ≈ $51.24 Million	CN¥74.23 Million ≈ $10.86 Million	0.212x	-42.12%
2012-12-31	CN¥285.34 Million ≈ $41.75 Million	CN¥104.50 Million ≈ $15.29 Million	0.366x	+18.31%
2011-12-31	CN¥225.51 Million ≈ $33.00 Million	CN¥69.81 Million ≈ $10.21 Million	0.310x	+12.70%
2010-12-31	CN¥170.81 Million ≈ $25.00 Million	CN¥46.92 Million ≈ $6.87 Million	0.275x	+26.99%
2009-12-31	CN¥103.18 Million ≈ $15.10 Million	CN¥22.32 Million ≈ $3.27 Million	0.216x	--

About Teyi Pharmaceutical Group Co Ltd

SHE:002728 China Drug Manufacturers - Specialty & Generic

Market Cap

$694.05 Million

CN¥4.74 Billion CNY

Market Cap Rank

#10518 Global

#2798 in China

Share Price

CN¥9.24

Change (1 day)

+3.36%

52-Week Range

CN¥8.00 - CN¥15.21

All Time High

CN¥129.24